Samuel Sarmiento

Samuel Sarmiento

Auto-generated profile, based on publicly available information

Samuel Sarmiento

Department of Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, 601 N. Caroline St., JHOC 8163, Baltimore, MD 21287, United States; Juniper Life Sciences, 1926 Third Ave, San Diego, CA 92101, United States

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Journal of Surgical Education
Verified
Journal Article
Closed access
RBRicardo J. Bello
Ricardo J. Bello
SSSamuel Sarmiento
Samuel Sarmiento
MMMeredith L. Meyer
Meredith L. Meyer
GRGedge D. Rosson
Gedge D. Rosson
DCDamon S. Cooney
Damon S. Cooney
CCCarisa M. Cooney
Carisa M. Cooney

10 February 2020 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
SSSamuel Sarmiento
Samuel Sarmiento
MMMichael McColl
Michael McColl
LMLeila Musavi
Leila Musavi
FGFaiz Gani
Faiz Gani
JCJoseph K. Canner
Joseph K. Canner
MHMehran Habibi
Mehran Habibi

29 September 2019 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
PDF file
SSSamuel Sarmiento
Samuel Sarmiento
CWCharles Wen
Charles Wen
MCMichael A Cheah
Michael A Cheah
SLStacey Lee
Stacey Lee
GRGedge D Rosson
Gedge D Rosson
Background: Malpractice litigation has a significant impact on healthcare costs and important professional implications for healthcare providers. Objectives: The authors sought to comprehensively characterize the litigation landscape in plastic surgery across its different subspecialties. Methods: The authors utilized the Westlaw legal database to conduct a comprehensive search of malpractice cases in the United States in the following categories: cosmetic, reconstructive, hand, craniofacial, and gender affirmation surgery. They conducted both a Boolean and a natural language search to identify cases in which a plastic surgeon was the defendant. Data were analyzed employing descriptive statistics, logistic regression, and relative risk calculations. Results: In total, 165 cases were included. Most surgeons accused of malpractice worked in a private setting (148 [90%]). Among the 22 (13%) cases that contained information on board certification status, most surgeons were board certified (17 [77%]). Resident involvement was mentioned in only 5 (3%) cases. The majority of cases were successfully defended by surgeons (98 [60%] vs 65 [40%]), particularly in craniofacial surgery (risk ratio: 1.54; P = 0.03; 95% CI: 1.03-2.3). Surgeons who successfully defended a case were more likely to benefit from summary judgment (P = 0.005). Conclusions: Malpractice litigation is commonplace in medical practice, and no specialty is spared. Legal outcomes were in favor of plastic surgeons in the majority of cases, particularly those that proceeded to summary judgment. Surgeons can avoid litigation by maintaining detailed office and surgical notes, always obtaining informed consent, adequately following and monitoring patients after surgery, and ensuring compliance by communicating frequently and effectively.

15 March 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
SSSamuel Sarmiento
Samuel Sarmiento
JJJames A Pierre Jr
James A Pierre Jr
ADA Lee Dellon
A Lee Dellon
KFKevin D Frick
Kevin D Frick
Objective To determine whether tibial neurolysis performed as a surgical intervention for patients with diabetic neuropathy and superimposed tibial nerve compression in the prevention of the diabetic foot is cost-effective when compared with the current prevention programme. Design A baseline analysis was built on a 5-year model to determine the cumulative incidence of foot ulcers and amputations with each strategy. Subsequently, a cost-effectiveness analysis and cohort-level Markov simulations were conducted with a model composed of 20 6-month cycles. A sensitivity analysis was also performed. Setting A Markov model was used to simulate the effects of standard prevention compared with tibial neurolysis on the long-term costs associated with foot ulcers and amputations. This model included eight health states. Participants Each cohort includes simulated patients with diabetic neuropathy at different levels of risk of developing foot ulcers and amputations. Primary and secondary outcome measures The primary outcome was the long-term trends concerning the development of ulcers and amputations with each strategy. The secondary outcome measures were quality adjusted life years (QALYs), incremental cost-effectiveness and net monetary benefits of the optimal strategy. Results When compared with standard prevention, for a patient population of 10 000, surgery prevented a simulated total of 1447 ulcers and 409 amputations over a period of 5 years. In a subsequent analysis that consisted of 20 6-month cycles (10 years), the incremental cost of tibial neurolysis compared with current prevention was $12 772.28; the incremental effectiveness was 0.41 QALYs and the incremental cost-effectiveness ratio was $31 330.78. Survival was 73% for those receiving medical prevention compared with 95% for those undergoing surgery. Conclusion These results suggest that among patients with diabetic neuropathy and superimposed nerve compression, surgery is more effective at preventing serious comorbidities and is associated with a higher survival over time. It also generated greater long-term economic benefits.

26 May 2025 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
UJUnser Jaffry
Unser Jaffry
CBCatherine Bienert
Catherine Bienert
DFDennis G. Foster
Dennis G. Foster
CSCharalampos Siotos
Charalampos Siotos
MMMichele A. Manahan
Michele A. Manahan
SSSamuel Sarmiento
Samuel Sarmiento